IL6 and chronic obstructive pulmonary disease: Given its capacity to suppress IL-6, TNF-α, and other inflammatory cytokines, let-7 also holds promise as a therapeutic agent to reduce COPD exacerbation frequency, particularly when used in conjunction with current anti-inflammatory treatments such as corticosteroids or phosphodiesterase-4 inhibitors [35,36].